Table of Contents

Articles

• You have access

  Metabolism of Selegiline in Humans

  Ho-Sang Shin

  Drug Metabolism and Disposition June 1997, 25 (6) 657-662;
• You have access

  Biotransformation of the Novel Inotropic Agent Toborinone (OPC-18790) in Rats and Dogs

  Mami Kitani, Gohachiro Miyamoto, Masakazu Nagasawa, Toshihide Yamada, Jun Matsubara, Minoru Uchida and Masaaki Odomi

  Drug Metabolism and Disposition June 1997, 25 (6) 663-674;
• You have access

  Prediction of Drug-Induced Catalepsy Based on Dopamine D₁, D₂, and Muscarinic Acetylcholine Receptor Occupancies

  Kaori Haraguchi, Kiyomi Ito, Hajime Kotaki, Yasufumi Sawada and Tatsuji Iga

  Drug Metabolism and Disposition June 1997, 25 (6) 675-684;
• You have access

  Stereoselective Metabolism of rac-Mexiletine by the Fungus Cunninghamella echinulata Yields the Major Human Metabolites Hydroxymethylmexiletine andp-Hydroxymexiletine

  D. G. Freitag, R. T. Foster, R. T. Coutts, M. A. Pickard and F. M. Pasutto

  Drug Metabolism and Disposition June 1997, 25 (6) 685-692;
• You have access

  Metabolism and Disposition of the Antifolate LY231514 in Mice and Dogs

  J. M. Woodland, C. J. Barnett, D. E. Dorman, J. M. Gruber, C. Shih, L. A. Spangle, T. M. Wilson and W. J. Ehlhardt

  Drug Metabolism and Disposition June 1997, 25 (6) 693-700;
• You have access

  Disposition and metabolism of the Sulfonylurea Oncolytic Agent LY295501 in Mouse, Rat, and Monkey

  William J. Ehlhardt, Joseph M. Woodland, John E. Toth, James E. Ray and Diana L. Martin

  Drug Metabolism and Disposition June 1997, 25 (6) 701-708;
• You have access

  Microbial Models of Mammalian Metabolism

  Geeta P. Rao and Patrick J. Davis

  Drug Metabolism and Disposition June 1997, 25 (6) 709-715;
• You have access

  CYTOCHROME P450 RESPONSIBLE FOR THE STEREOSELECTIVES-OXIDATION OF FLOSEQUINAN IN HEPATIC MICROSOMES FROM RATS AND HUMANS

  Eiji Kashiyama, Tsuyoshi Yokoi, Masaaki Odomi, Yoshihiko Funae, Kazuaki Inoue and Tetsuya Kamataki

  Drug Metabolism and Disposition June 1997, 25 (6) 716-724;
• You have access

  Purification and ¹H NMR Spectroscopic Characterization of Phase II Metabolites of Tolfenamic Acid

  Ulla Grove Sidelmann, Eyøhild Christiansen, Line Krogh, Claus Cornett and Jette Tjørnelund, and Steen Honoré Hansen

  Drug Metabolism and Disposition June 1997, 25 (6) 725-731;
• You have access

  Oral and Topical Absorption, Disposition Kinetics, and the Metabolic Fate of trans-Methyl Styryl Ketone in the Male Fischer 344 Rat

  John-Michael Sauer, Richard L. Smith, Jingqi Bao, Margaret J. Kattnig, Robert K. Kuester, Thomas D. McClure, Michael Mayersohn and I. Glenn Sipes

  Drug Metabolism and Disposition June 1997, 25 (6) 732-739;
• You have access

  Hydroxylation and Demethylation of the Tricyclic Antidepressant Nortriptyline by cDNA-Expressed Human Cytochrome P-450 Isozymes

  Ole V. Olesen and Kristian Linnet

  Drug Metabolism and Disposition June 1997, 25 (6) 740-744;
• You have access

  Baculovirus-Directed Expression of Rabbit UDP-Glucuronosyltransferases in Spodoptera frugiperda Cells

  Nghia Nguyen and Robert H. Tukey

  Drug Metabolism and Disposition June 1997, 25 (6) 745-749;
• You have access

  In Vivo Induction and in Vitro Inhibition of Hepatic Cytochrome P450 Activity by the Benzodiazepine Anticonvulsants Clonazepam and Diazepam

  Raymond W. Nims, Russell A. Prough, Collins R. Jones, Diana L. Stockus, Konstantin H. Dragnev, Paul E. Thomas and Ronald A. Lubet

  Drug Metabolism and Disposition June 1997, 25 (6) 750-756;
• You have access

  Induction of Cytochrome P4503A by the Antiglucocorticoid Mifepristone and a Novel Hypocholesterolaemic Drug

  J. Andrew Williams, Richard J. Chenery, Theo A. Berkhout and Gabrielle M. Hawksworth

  Drug Metabolism and Disposition June 1997, 25 (6) 757-761;
• You have access

  Inhibitory Anti-Peptide Antibody Against Human CYP3A4

  Regina W. Wang and Anthony Y. H. Lu

  Drug Metabolism and Disposition June 1997, 25 (6) 762-767;